Review Article
Meta-Analysis of Clinical Efficacy and Safety of Tripterygium wilfordii Polyglycosides Tablets in the Treatment of Chronic Kidney Disease
Table 6
Meta-analysis of elevated serum albumin levels in the experimental group and the control group.
| | Subgroup analysis | No. of studies | Weighted combination | Heterogeneity | Egger’s bias
value | Metaregression
value | | WMD [95% conf. interval] | value | I2 | value |
| | Disease type | | NS | 20 | 4.407 (2.843, 5.971) | | 92.3% | | | | | RNS | 12 | 5.726 (3.692, 7.760) | | 95.1% | | | | PNS | 10 | 3.796 (1.347, 6.245) | | 94.7% | | | | MN | 2 | 2.34 (-0.793, 5.483) | | 38.2% | | | | IgAN | 1 | 4.600 (0.484, 8.716) | | — | — | — |
| | Mode of medication | | Single drug | 5 | 5.649 (4.712, 6.585) | | 17.7% | | | | | Combined use of drugs | 40 | 4.448 (3.296, 5.600) | | 93.9% | | |
| | Course of treatment | | <6 months | 14 | 4.679 (3.050, 6.309) | | 92.4% | | | | | ≥6 months | 16 | 5.483 (3.455, 7.510) | | 94.2% | | | | ≥12 months | 14 | 3.154 (1.468, 4.84) | | 91.3% | | | | Not reported | 1 | 7.920 (5.581, 10.259) | | — | — | — |
| | Age of the patient (year) | | 0–18 | 1 | 4.600 (0.484, 8.716) | | — | | — | | | 19–65 | 35 | 4.606 (3.470, 5.743) | | 91.3% | | | | >66 | 12 | 4.438 (2.110, 6.765) | | 96.1% | | | | Total | 45 | 4.557 (3.523, 5.592) | | 93.2% | | | — |
|
|
